Genomic & Biopharma NewsNew resource-based approach to improve HIV care in low- and middle-income countries
A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.
|News Medical Life Sciences, 2019-01-18 10:35:23|
Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board
Bedfont announces today that Dr Jafar Jafari will be the first appointment to its Gastrolyzer Medical Advisory Board.
|News Medical Life Sciences, 2019-01-18 10:33:00|
Study evaluates first-ever Robotic Visualization System for neurosurgery
A one-year study was recently conducted to perform a comprehensive assessment of the new, cutting-edge ZEISS KINEVO 900, a first-ever Robotic Visualization System® and compares its performance to the previous model of ZEISS surgical microscope.
|News Medical Life Sciences, 2019-01-18 10:32:00|
HeartFlow Analysis shows highest diagnostic performance for detecting coronary artery disease
HeartFlow, Inc. today announced the publication of the PACIFIC substudy showing that the HeartFlow FFRct Analysis demonstrates the highest diagnostic performance for detecting coronary artery disease compared to other non-invasive tests.
|News Medical Life Sciences, 2019-01-18 10:30:02|
INTEGRA Biosciences offers chance to win a VIAFLO 96/384 pipette
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette.
|News Medical Life Sciences, 2019-01-18 10:30:00|
Pelican Newspaper: Gene profiling at Ocean Ridge Biosciences to unlock mysteries of the human body
Identifying the markers for pancreatic cancer may have happened here in a 5,400 square foot facility where scientists routinely practice next generation RNA profiling and biomarker discovery. Please read the PDF for more details
|ORB Company News, 2016-11-25 18:55:37|
FiercePharmaAsia—Gilead’s clinical VP; Aurobindo buys Spectrum assets; Aslan’s lead drug
Gilead loses its vice president of clinical research to NASH-focused Terns; Spectrum unloads its marketed portfolio to India's Aurobindo in a deal worth $300 million; Aslan's lead drug varlitinib misses the mark in a gastric cancer trial; and more.
|Fierce Pharma, 2019-01-18 09:57:13|
Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
Sleeping more than nine hours per night during pregnancy may be associated with late stillbirth, a new Michigan Medicine-led international study suggests.
|News Medical Life Sciences, 2019-01-18 09:36:44|
Palm Beach Post: ORB Leaves Palm Beach County for New Lab Space
David Willoughby lives in Palm Beach Gardens and, until recently, worked there too. But the owner of Ocean Ridge Biosciences wanted to expand, and he couldn't find suitable space in northern Palm Beach County. Please read the PDF for more details
|ORB Company News, 2016-12-02 15:35:33|
Bioethicists call for oversight of poorly regulated, consumer-grade neurotechnology products
The marketing of direct-to-consumer "neurotechnologies" can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or "read" one's emotional state. However, many of these increasingly popular products aren't fully supported by science and have little to no regulatory oversight, which poses potential health risks to the public.
|News Medical Life Sciences, 2019-01-18 08:39:12|
Study uses local data to model food consumption patterns among Seattle residents
Seattle residents who live in waterfront neighborhoods tend to have healthier diets compared to those who live along Interstate-5 and Aurora Avenue, according to new research on social disparities from the University of Washington School of Public Health.
|News Medical Life Sciences, 2019-01-18 08:26:36|